Cargando…
A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial
BACKGROUND: This study assessed whether a theoretically conceptualised tailored intervention centred on multidisciplinary teams (MDTs) increased clinician referral behaviours in line with clinical practice guideline recommendations. METHODS: Nine hospital Sites in New South Wales (NSW), Australia wi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848547/ https://www.ncbi.nlm.nih.gov/pubmed/29530071 http://dx.doi.org/10.1186/s13012-018-0733-x |
_version_ | 1783305891053830144 |
---|---|
author | Brown, Bernadette Young, Jane Smith, David P. Kneebone, Andrew B. Brooks, Andrew J. Egger, Sam Xhilaga, Miranda Dominello, Amanda O’Connell, Dianne L. Haines, Mary |
author_facet | Brown, Bernadette Young, Jane Smith, David P. Kneebone, Andrew B. Brooks, Andrew J. Egger, Sam Xhilaga, Miranda Dominello, Amanda O’Connell, Dianne L. Haines, Mary |
author_sort | Brown, Bernadette |
collection | PubMed |
description | BACKGROUND: This study assessed whether a theoretically conceptualised tailored intervention centred on multidisciplinary teams (MDTs) increased clinician referral behaviours in line with clinical practice guideline recommendations. METHODS: Nine hospital Sites in New South Wales (NSW), Australia with a urological MDT and involvement in a state-wide urological clinical network participated in this pragmatic stepped wedge, cluster randomised implementation trial. Intervention strategies included flagging of high-risk patients by pathologists, clinical leadership, education, and audit and feedback of individuals’ and study Sites’ practices. The primary outcome was the proportion of patients referred to radiation oncology within 4 months after prostatectomy. Secondary outcomes were proportion of patients discussed at a MDT meeting within 4 months after surgery; proportion of patients who consulted a radiation oncologist within 6 months; and the proportion who commenced radiotherapy within 6 months. Urologists’ attitudes towards adjuvant radiotherapy were surveyed pre- and post-intervention. A process evaluation measured intervention fidelity, response to intervention components and contextual factors that impacted on implementation and sustainability. RESULTS: Records for 1071 high-risk post-RP patients operated on by 37 urologists were reviewed: 505 control-phase; and 407 intervention-phase. The proportion of patients discussed at a MDT meeting increased from 17% in the control-phase to 59% in the intervention-phase (adjusted RR = 4.32; 95% CI [2.40 to 7.75]; p < 0·001). After adjustment, there was no significant difference in referral to radiation oncology (intervention 32% vs control 30%; adjusted RR = 1.06; 95% CI [0.74 to 1.51]; p = 0.879). Sites with the largest relative increases in the percentage of patients discussed also tended to have greater increases in referral (p = 0·001). In the intervention phase, urologists failed to provide referrals to more than half of patients whom the MDT had recommended for referral (78 of 140; 56%). CONCLUSIONS: The intervention resulted in significantly more patients being discussed by a MDT. However, the recommendations from MDTs were not uniformly recorded or followed. Although practice varied markedly between MDTs, the intervention did not result in a significant overall change in referral rates, probably reflecting a lack of change in urologists’ attitudes. Our results suggest that interventions focused on structures and processes that enable health system-level change, rather than those focused on individual-level change, are likely to have the greatest effect. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12611001251910). Registered 6 December 2011. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13012-018-0733-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5848547 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58485472018-03-21 A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial Brown, Bernadette Young, Jane Smith, David P. Kneebone, Andrew B. Brooks, Andrew J. Egger, Sam Xhilaga, Miranda Dominello, Amanda O’Connell, Dianne L. Haines, Mary Implement Sci Research BACKGROUND: This study assessed whether a theoretically conceptualised tailored intervention centred on multidisciplinary teams (MDTs) increased clinician referral behaviours in line with clinical practice guideline recommendations. METHODS: Nine hospital Sites in New South Wales (NSW), Australia with a urological MDT and involvement in a state-wide urological clinical network participated in this pragmatic stepped wedge, cluster randomised implementation trial. Intervention strategies included flagging of high-risk patients by pathologists, clinical leadership, education, and audit and feedback of individuals’ and study Sites’ practices. The primary outcome was the proportion of patients referred to radiation oncology within 4 months after prostatectomy. Secondary outcomes were proportion of patients discussed at a MDT meeting within 4 months after surgery; proportion of patients who consulted a radiation oncologist within 6 months; and the proportion who commenced radiotherapy within 6 months. Urologists’ attitudes towards adjuvant radiotherapy were surveyed pre- and post-intervention. A process evaluation measured intervention fidelity, response to intervention components and contextual factors that impacted on implementation and sustainability. RESULTS: Records for 1071 high-risk post-RP patients operated on by 37 urologists were reviewed: 505 control-phase; and 407 intervention-phase. The proportion of patients discussed at a MDT meeting increased from 17% in the control-phase to 59% in the intervention-phase (adjusted RR = 4.32; 95% CI [2.40 to 7.75]; p < 0·001). After adjustment, there was no significant difference in referral to radiation oncology (intervention 32% vs control 30%; adjusted RR = 1.06; 95% CI [0.74 to 1.51]; p = 0.879). Sites with the largest relative increases in the percentage of patients discussed also tended to have greater increases in referral (p = 0·001). In the intervention phase, urologists failed to provide referrals to more than half of patients whom the MDT had recommended for referral (78 of 140; 56%). CONCLUSIONS: The intervention resulted in significantly more patients being discussed by a MDT. However, the recommendations from MDTs were not uniformly recorded or followed. Although practice varied markedly between MDTs, the intervention did not result in a significant overall change in referral rates, probably reflecting a lack of change in urologists’ attitudes. Our results suggest that interventions focused on structures and processes that enable health system-level change, rather than those focused on individual-level change, are likely to have the greatest effect. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12611001251910). Registered 6 December 2011. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13012-018-0733-x) contains supplementary material, which is available to authorized users. BioMed Central 2018-03-12 /pmc/articles/PMC5848547/ /pubmed/29530071 http://dx.doi.org/10.1186/s13012-018-0733-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Brown, Bernadette Young, Jane Smith, David P. Kneebone, Andrew B. Brooks, Andrew J. Egger, Sam Xhilaga, Miranda Dominello, Amanda O’Connell, Dianne L. Haines, Mary A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial |
title | A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial |
title_full | A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial |
title_fullStr | A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial |
title_full_unstemmed | A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial |
title_short | A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial |
title_sort | multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: a stepped-wedge cluster randomised implementation trial |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848547/ https://www.ncbi.nlm.nih.gov/pubmed/29530071 http://dx.doi.org/10.1186/s13012-018-0733-x |
work_keys_str_mv | AT brownbernadette amultidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial AT youngjane amultidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial AT smithdavidp amultidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial AT kneeboneandrewb amultidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial AT brooksandrewj amultidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial AT eggersam amultidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial AT xhilagamiranda amultidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial AT dominelloamanda amultidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial AT oconnelldiannel amultidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial AT hainesmary amultidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial AT brownbernadette multidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial AT youngjane multidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial AT smithdavidp multidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial AT kneeboneandrewb multidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial AT brooksandrewj multidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial AT eggersam multidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial AT xhilagamiranda multidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial AT dominelloamanda multidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial AT oconnelldiannel multidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial AT hainesmary multidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial |